Black Diamond Therapeutics Financial Overview
Black Diamond Therapeutics's market cap is currently $147.57M. The company's EPS TTM is $-0.15; its P/E ratio is 7.00; Black Diamond Therapeutics is scheduled to report earnings on November 6, 2025, and the estimated EPS forecast is $-0.18. See an overview of income statement, balance sheet, and cash flow financials.
